41 results on '"Garcia-Lerma, J. Gerardo"'
Search Results
2. Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy
3. Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa
4. The menstrual cycle regulates migratory CD4 T-cell surveillance in the female reproductive tract via CCR5 signaling
5. Corrigendum to – “Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques” [eBioMedicine 58(2020) 102894]
6. Increased Ability for Selection of Zidovudine Resistance in a Distinct Class of Wild-Type HIV-1 from Drug-Naive Persons
7. Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection
8. Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis
9. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir
10. Memory CD4 T cell subset organization in the female reproductive tract is regulated via the menstrual cycle through CCR5 signaling
11. Prophylactic Efficacy of Oral Emtricitabine and Tenofovir Disoproxil Fumarate Combination Therapy Against a Tenofovir-Resistant Simian/Human Immunodeficiency Virus Containing the K65R Mutation in Macaques
12. Reduced Inflammation and CD4 Loss in Acute SHIV Infection During Oral Pre-Exposure Prophylaxis
13. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis
14. Single Dose Topical Inserts Containing Tenofovir Alafenamide Fumarate and Elvitegravir Provide Pre- and Post-Exposure Protection Against Vaginal Shiv Infection in Macaques
15. Pharmacokinetics and Efficacy of Topical Inserts Containing Tenofovir Alafenamide Fumarate and Elvitegravir Administered Rectally in Macaques
16. The Epidemiology of Antiretroviral Drug Resistance among Drug-Naive HIV-1-Infected Persons in 10 US Cities
17. Susceptibility of Human T Cell Leukemia Virus Type 1 to Reverse-Transcriptase Inhibitors: Evidence for Resistance to Lamivudine
18. On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors
19. Genital Immune Cell Activation and Tenofovir Gel Efficacy: A Case-Control Study.
20. Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
21. Antiretroviral drug exposure in urethral and glans surface sampling of the penis
22. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
23. Proinflammatory Oscillations Over the Menstrual Cycle Drives Bystander CD4 T Cell Recruitment and SHIV Susceptibility from Vaginal Challenge
24. Mutation rate and the efficacy of antimicrobial drug treatment
25. Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques
26. Differential localization of distinct CD4 T cell subsets in the female genital tract during the menstrual cycle is regulated by CCR5
27. SHIV susceptibility changes during the menstrual cycle of pigtail macaques
28. Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors
29. Susceptibility to Repeated, Low-Dose, Rectal SHIVSF162P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques
30. Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks
31. T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis
32. Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques
33. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance
34. Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine
35. Repeated Rectal SHIVSF162P3Exposures Do Not Consistently Induce Sustained T Cell Responses Prior to Systemic Infection in the Repeat-Low Dose Preclinical Macaque Model
36. Short Communication:No Evidence of Occult SHIV Infection as Demonstrated by CD8+Cell Depletion after Chemoprophylaxis-Induced Protection from Mucosal Infection in Rhesus Macaques
37. Susceptibility to Repeated, Low-Dose, Rectal SHIVSFi62P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques.
38. Effect of Mobile Phase pH and Organic Content on LC–MS Analysis of Nucleoside and Nucleotide HIV Reverse Transcriptase Inhibitors.
39. Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection.
40. Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model.
41. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.